Healthcare provider profile · identity verified

Steven David Ramos, M.D.

Internal Medicine · SAN ANTONIO, TX · NPI 1972942738

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	692	208
Levothyroxine Sodium	Levothyroxine Sodium	478	142
Rosuvastatin Calcium	Rosuvastatin Calcium	382	119
Amlodipine Besylate	Amlodipine Besylate	355	104
Losartan Potassium	Losartan Potassium	340	100
Lisinopril	Lisinopril	320	99
Metformin Hcl	Metformin Hcl	262	89
Fluticasone Propionate	Fluticasone Propionate	226	89
Gabapentin	Gabapentin	199	62
Tamsulosin Hcl	Tamsulosin Hcl	186	66
Carvedilol	Carvedilol	184	57
Meloxicam	Meloxicam	179	73
Hydrochlorothiazide	Hydrochlorothiazide	163	56
Furosemide	Furosemide	154	49
Albuterol Sulfate Hfa	Albuterol Sulfate	146	46
Famotidine	Famotidine	141	56
Pantoprazole Sodium	Pantoprazole Sodium	140	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	136	31
Irbesartan	Irbesartan	127	40
Metoprolol Succinate	Metoprolol Succinate	127	40
Omeprazole	Omeprazole	126	41
Tramadol Hcl	Tramadol Hcl	126	30
Trazodone Hcl	Trazodone Hcl	124	35
Alprazolam	Alprazolam	121	21
Vitamin D2	Ergocalciferol (Vitamin D2)	121	40
Montelukast Sodium	Montelukast Sodium	115	36
Ozempic	Semaglutide	110	22
Mounjaro	Tirzepatide	101	22
Clopidogrel	Clopidogrel Bisulfate	99	35
Jardiance	Empagliflozin	99	28
Alendronate Sodium	Alendronate Sodium	97	33
Duloxetine Hcl	Duloxetine Hcl	97	25
Eliquis	Apixaban	90	26
Pravastatin Sodium	Pravastatin Sodium	90	25
Prednisone	Prednisone	90	74
Metoprolol Tartrate	Metoprolol Tartrate	84	29
Chlorthalidone	Chlorthalidone	81	23
Glipizide	Glipizide	80	26
Simvastatin	Simvastatin	79	25
Sertraline Hcl	Sertraline Hcl	74	24
Trulicity	Dulaglutide	74	16
Escitalopram Oxalate	Escitalopram Oxalate	71	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	23
Glipizide Er	Glipizide	70	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	39
Finasteride	Finasteride	61	19
Nifedipine Er	Nifedipine	60	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	17
Potassium Chloride	Potassium Chloride	59	17
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	58	17
Januvia	Sitagliptin Phosphate	57	14
Allopurinol	Allopurinol	55	15
Folic Acid	Folic Acid	55	14
Bupropion Xl	Bupropion Hcl	53	18
Mirtazapine	Mirtazapine	53	17
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	49	13
Acetaminophen-Codeine	Acetaminophen With Codeine	41	16
Olmesartan Medoxomil	Olmesartan Medoxomil	40	13
Diclofenac Sodium	Diclofenac Sodium	38	13
Metformin Hcl Er	Metformin Hcl	38	12
Farxiga	Dapagliflozin Propanediol	36	11
Azithromycin	Azithromycin	35	32
Oxybutynin Chloride	Oxybutynin Chloride	34	13
Torsemide	Torsemide	32	suppressed
Tresiba Flextouch U-100	Insulin Degludec	32	suppressed
Benazepril Hcl	Benazepril Hcl	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	13
Temazepam	Temazepam	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Glyxambi	Empagliflozin/Linagliptin	27	11
Lovastatin	Lovastatin	27	suppressed
Ondansetron Odt	Ondansetron	27	14
Soliqua 100-33	Insulin Glargine/Lixisenatide	26	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Incontrol Pen Needle	Pen Needle, Diabetic	25	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	21
Rexulti	Brexpiprazole	24	suppressed
Valsartan	Valsartan	24	suppressed
Nebivolol Hcl	Nebivolol Hcl	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	22	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	15
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Spironolactone	Spironolactone	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Belsomra	Suvorexant	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Atenolol	Atenolol	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Cephalexin	Cephalexin	12	12
Entresto	Sacubitril/Valsartan	12	suppressed
Linzess	Linaclotide	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error